Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Goodwill (2018 - 2025)

Historic Goodwill for Rocket Pharmaceuticals (RCKT) over the last 8 years, with Q3 2025 value amounting to $39.2 million.

  • Rocket Pharmaceuticals' Goodwill changed 0.0% to $39.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $39.2 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Rocket Pharmaceuticals' Goodwill stood at $39.2 million, which was down 0.0% from $39.2 million recorded in Q2 2025.
  • Rocket Pharmaceuticals' 5-year Goodwill high stood at $39.2 million for Q4 2022, and its period low was $30.8 million during Q1 2021.
  • Its 5-year average for Goodwill is $36.1 million, with a median of $39.2 million in 2022.
  • In the last 5 years, Rocket Pharmaceuticals' Goodwill changed by 0.0% in 2021 and then skyrocketed by 2721.08% in 2022.
  • Rocket Pharmaceuticals' Goodwill (Quarter) stood at $30.8 million in 2021, then increased by 27.21% to $39.2 million in 2022, then changed by 0.0% to $39.2 million in 2023, then changed by 0.0% to $39.2 million in 2024, then changed by 0.0% to $39.2 million in 2025.
  • Its Goodwill was $39.2 million in Q3 2025, compared to $39.2 million in Q2 2025 and $39.2 million in Q1 2025.